Add to Watchlist Create Alerts

Real-Time Last Update

Last Sale Cboe BZX Real-Time

Volume

TRACON Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

Globe Newswire - Wed Jan 5, 2022

SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright BIOCONNECT Virtual Conference, being held January 10-13, 2022.

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

investor newsletter

A change in market leadership may be imminent. Plus, an index-beating U.S. dividend portfolio strategy

Tensions rise in Silicon Valley over sales of startup stocks

inside the market

How pro money managers are balancing exposure to Canadian and U.S. stocks

At the open: North American stock markets rise as rate-cut hopes linger

The close: Wall Street sharply higher as nonfarm payrolls report strengthens case for rate cuts in both the U.S. and Canada

The close: Major North American indexes higher, led by Nasdaq, amid plethora of mixed earnings

international business

Trump awarded 36 million more Trump Media shares worth $1.8-billion after hitting price benchmarks

The close: Stocks mixed as Fed leaves investors guessing as to when rate cuts will arrive